Financials Braskem S.A.

Equities

BRKM5

BRBRKMACNPA4

Commodity Chemicals

Market Closed - Sao Paulo 04:07:00 2024-07-05 pm EDT 5-day change 1st Jan Change
18.31 BRL -18.73% Intraday chart for Braskem S.A. +2.52% -16.24%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 24,521 19,504 45,482 19,609 17,347 14,661 - -
Enterprise Value (EV) 1 60,375 59,264 84,361 19,609 73,323 55,089 52,342 48,600
P/E ratio -8.49 x -2.8 x 3.28 x -56.4 x -3.8 x -5.52 x 13.5 x 5.06 x
Yield 2.82% - 14.1% - - 0% - 4.86%
Capitalization / Revenue 0.47 x 0.33 x 0.43 x 0.2 x 0.25 x 0.19 x 0.18 x 0.17 x
EV / Revenue 1.15 x 1.01 x 0.8 x 0.2 x 1.04 x 0.72 x 0.63 x 0.57 x
EV / EBITDA 16.9 x 5.4 x 2.44 x 1.85 x 19.6 x 8.26 x 5.18 x 4.05 x
EV / FCF -145 x 16.8 x 7.42 x - -10.8 x 14.4 x 8.99 x 6.28 x
FCF Yield -0.69% 5.96% 13.5% - -9.28% 6.92% 11.1% 15.9%
Price to Book 4.86 x -8.52 x 5.83 x - 4.36 x 6.89 x 3.15 x 2.07 x
Nbr of stocks (in thousands) 795,742 795,744 796,066 796,303 796,968 796,968 - -
Reference price 2 29.85 23.57 57.63 23.76 21.86 18.25 18.25 18.25
Announcement Date 4/4/20 3/11/21 3/16/22 3/22/23 3/19/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 52,324 58,543 105,625 96,519 70,569 76,304 83,009 85,277
EBITDA 1 3,576 10,975 34,507 10,571 3,737 6,673 10,102 11,989
EBIT 1 -57 -72 26,044 5,838 -1,469 1,676 5,252 7,642
Operating Margin -0.11% -0.12% 24.66% 6.05% -2.08% 2.2% 6.33% 8.96%
Earnings before Tax (EBT) 1 -4,803 -9,684 17,961 47 -6,192 -4,311 645.5 2,758
Net income 1 -2,798 -6,692 14,000 -336 -4,579 -2,798 693.7 2,817
Net margin -5.35% -11.43% 13.25% -0.35% -6.49% -3.67% 0.84% 3.3%
EPS 2 -3.515 -8.407 17.57 -0.4215 -5.746 -3.307 1.349 3.607
Free Cash Flow 1 -417.2 3,533 11,365 - -6,802 3,813 5,821 7,737
FCF margin -0.8% 6.03% 10.76% - -9.64% 5% 7.01% 9.07%
FCF Conversion (EBITDA) - 32.19% 32.94% - - 57.14% 57.62% 64.53%
FCF Conversion (Net income) - - 81.18% - - - 839.12% 274.69%
Dividend per Share 2 0.8404 - 8.145 - - 0.000010 - 0.8865
Announcement Date 4/4/20 3/11/21 3/16/22 3/22/23 3/19/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 28,212 26,731 25,411 25,387 18,990 19,446 17,756 16,676 16,691 17,920 18,406 18,460 18,271 - -
EBITDA 1 7,682 4,845 3,927 1,967 -168 1,063 703 921 1,049 1,140 1,663 1,619 1,866 2,454 2,712
EBIT 1 3,722 3,844 1,654 691 -1,599 -167 -601 -364 -337 -41 675.3 368.7 515.1 - -
Operating Margin 13.19% 14.38% 6.51% 2.72% -8.42% -0.86% -3.38% -2.18% -2.02% -0.23% 3.67% 2% 2.82% - -
Earnings before Tax (EBT) 1 1,248 5,018 -1,738 -1,005 -2,227 144.2 -1,480 -3,030 -1,827 -2,071 -1,169 -848.1 -417.5 - -
Net income 1 500 3,884 -1,406 -1,103 -1,710 184 -771 -2,418 -1,575 -1,345 -868.5 -581.7 -476.4 - -
Net margin 1.77% 14.53% -5.53% -4.34% -9% 0.95% -4.34% -14.5% -9.44% -7.51% -4.72% -3.15% -2.61% - -
EPS 2 0.6659 4.879 -1.764 -1.384 -2.153 0.2309 -0.9674 -3.034 -1.975 -1.688 -0.9911 -0.6814 -0.5235 0.6300 0.7500
Dividend per Share 2 8.145 - - - - - - - - - - - - - -
Announcement Date 3/16/22 5/11/22 8/10/22 11/9/22 3/22/23 5/8/23 8/9/23 11/9/23 3/19/24 5/9/24 - - - - -
1BRL in Million2BRL
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 35,855 39,760 38,879 - 55,976 40,428 37,681 33,939
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 10.03 x 3.623 x 1.127 x - 14.98 x 6.058 x 3.73 x 2.831 x
Free Cash Flow 1 -417 3,533 11,365 - -6,802 3,813 5,821 7,737
ROE (net income / shareholders' equity) -47.9% -499% 494% - -62.4% -114% 18.7% 58.1%
ROA (Net income/ Total Assets) -4.39% -8.68% 15.7% - -3.93% -2.13% 0.75% 2.83%
Assets 1 63,672 77,110 89,420 - 116,523 131,187 92,554 99,456
Book Value Per Share 2 6.140 -2.770 9.880 - 5.010 2.650 5.790 8.830
Cash Flow per Share 2 2.850 7.910 18.50 - -2.850 1.420 7.950 6.830
Capex 1 2,683 2,760 3,421 - 4,530 2,495 2,975 3,400
Capex / Sales 5.13% 4.71% 3.24% - 6.42% 3.27% 3.58% 3.99%
Announcement Date 4/4/20 3/11/21 3/16/22 3/22/23 3/19/24 - - -
1BRL in Million2BRL
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
18.25 BRL
Average target price
26.71 BRL
Spread / Average Target
+46.35%
Consensus
  1. Stock Market
  2. Equities
  3. BRKM5 Stock
  4. Financials Braskem S.A.